2023
DOI: 10.3390/cancers15030823
|View full text |Cite
|
Sign up to set email alerts
|

Radiomics-Based Inter-Lesion Relation Network to Describe [18F]FMCH PET/CT Imaging Phenotypes in Prostate Cancer

Abstract: Advanced image analysis, including radiomics, has recently acquired recognition as a source of biomarkers, although there are some technical and methodological challenges to face for its application in the clinic. Among others, proper phenotyping of metastatic or systemic disease where multiple lesions coexist is an issue, since each lesion contributes to characterization of the disease. Therefore, the radiomic profile of each lesion should be modeled into a more complex architecture able to reproduce each “un… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
3
2

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(2 citation statements)
references
References 37 publications
0
2
0
Order By: Relevance
“…Most published radiomic studies extract radiomic features from only one lesion, even in multi metastatic patients. While analyzing a single lesion may be less time-consuming and involve simpler mathematical models, it may also lead to misevaluation of the cancer inter-lesion heterogeneity [7], [17], [40], [41]. This is especially consequential in the context of predicting patient-specific outcomes such as overall treatment response or patient survival; hence, we sought only to predict tumor response at a lesion level.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Most published radiomic studies extract radiomic features from only one lesion, even in multi metastatic patients. While analyzing a single lesion may be less time-consuming and involve simpler mathematical models, it may also lead to misevaluation of the cancer inter-lesion heterogeneity [7], [17], [40], [41]. This is especially consequential in the context of predicting patient-specific outcomes such as overall treatment response or patient survival; hence, we sought only to predict tumor response at a lesion level.…”
Section: Discussionmentioning
confidence: 99%
“…Patients who relapse with a single metastatic lesion can occasionally be cured by surgery or radiotherapy, but single metastases are the exception rather than the rule [5], [6]. Unfortunately, metastatic sites develop unique phenotypes and genotypes [7], [8]. As such, eradicating a subset of metastatic lesions in a patient is not likely to provide adequate long-term disease control.…”
Section: Introductionmentioning
confidence: 99%